Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24.1	51.47	21.66	16.35	11.94	130.98
Short-Term Investments	55.79	40.28	53.17	88.92	128.88	-
Cash & Short-Term Investments	79.89	91.75	74.82	105.27	140.82	130.98
Cash Growth	18.90%	22.62%	-28.92%	-25.25%	7.51%	1184.72%
Accounts Receivable	0.41	0.77	0.29	0.77	0.54	0.32
Other Receivables	-	0.4	0.6	-	-	-
Receivables	0.41	1.17	0.89	0.77	0.54	0.32
Prepaid Expenses	2.42	2.14	1.7	5.25	4.77	2.06
Total Current Assets	82.71	95.05	77.41	111.28	146.13	133.36
Property, Plant & Equipment	1.84	2.07	2.95	3.52	3.18	0.97
Other Long-Term Assets	0.26	0.07	1.28	1.39	0.24	0.4
Total Assets	84.81	97.19	81.64	116.19	149.54	134.73
Accounts Payable	3.63	4.82	1.97	1.96	1.44	1.37
Accrued Expenses	8.95	7.9	7.78	5.18	4.11	3.46
Current Portion of Leases	0.72	0.71	0.69	0.68	0.55	0.86
Other Current Liabilities	-	-	-	-	0.46	0.43
Total Current Liabilities	13.29	13.43	10.44	7.81	6.56	6.12
Long-Term Leases	0.64	0.81	1.46	2.04	2.57	0.01
Other Long-Term Liabilities	-	-	-	-	-	0.44
Total Liabilities	13.93	14.24	11.9	9.85	9.13	6.57
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	468.46	467.09	409.34	404.83	400.5	361.82
Retained Earnings	-397.61	-384.18	-339.54	-298.1	-259.81	-231.5
Comprehensive Income & Other	0.03	0.03	-0.07	-0.4	-0.28	-2.17
Total Common Equity	70.88	82.95	69.74	106.34	140.42	128.16
Shareholders' Equity	70.88	82.95	69.74	106.34	140.42	128.16
Total Liabilities & Equity	84.81	97.19	81.64	116.19	149.54	134.73
Total Debt	1.36	1.52	2.15	2.72	3.12	0.87
Net Cash (Debt)	78.53	90.22	72.67	102.55	137.7	130.11
Net Cash Growth	20.46%	24.15%	-29.13%	-25.53%	5.83%	1436.34%
Net Cash Per Share	1.48	1.89	1.63	2.35	3.53	6.23
Filing Date Shares Outstanding	66.53	66.52	44.68	44.68	43.31	37.05
Total Common Shares Outstanding	66.53	66.52	44.68	44.68	41.96	36.78
Working Capital	69.42	81.63	66.97	103.48	139.57	127.24
Book Value Per Share	1.07	1.25	1.56	2.38	3.35	3.48
Tangible Book Value	70.88	82.95	69.74	106.34	140.42	128.16
Tangible Book Value Per Share	1.07	1.25	1.56	2.38	3.35	3.48
Machinery	-	2.47	2.42	2.12	1.86	1.67
Leasehold Improvements	-	2.57	2.57	2.56	1.96	1.96

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q